These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 11037892

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A cost effectiveness analysis of treatment options for methotrexate-naive rheumatoid arthritis.
    Choi HK, Seeger JD, Kuntz KM.
    J Rheumatol; 2002 Jun; 29(6):1156-65. PubMed ID: 12064828
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Dose escalation of parenteral methotrexate in active rheumatoid arthritis that has been unresponsive to conventional doses of methotrexate: a randomized, controlled trial.
    Lambert CM, Sandhu S, Lochhead A, Hurst NP, McRorie E, Dhillon V.
    Arthritis Rheum; 2004 Feb; 50(2):364-71. PubMed ID: 14872477
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Current aspects of cost effectiveness of TNF-alpha blocking agents in patients with rheumatoid arthritis].
    Merkesdal S, Ruof J.
    Z Rheumatol; 2002 Feb; 61 Suppl 2():II/29-32. PubMed ID: 12491120
    [Abstract] [Full Text] [Related]

  • 10. An economic approach to health care.
    Homik JE, Suarez-Almazor M.
    Best Pract Res Clin Rheumatol; 2004 Apr; 18(2):203-18. PubMed ID: 15121040
    [Abstract] [Full Text] [Related]

  • 11. Pretreatment cytokine profiles of peripheral blood mononuclear cells and serum from patients with rheumatoid arthritis in different american college of rheumatology response groups to methotrexate.
    Seitz M, Zwicker M, Villiger PM.
    J Rheumatol; 2003 Jan; 30(1):28-35. PubMed ID: 12508386
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Certolizumab pegol (CIMZIA®) for the treatment of rheumatoid arthritis.
    Connock M, Tubeuf S, Malottki K, Uthman A, Round J, Bayliss S, Meads C, Moore D.
    Health Technol Assess; 2010 Oct; 14(Suppl. 2):1-10. PubMed ID: 21047485
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Factors predicting response to treatment in rheumatoid arthritis: the importance of disease duration.
    Anderson JJ, Wells G, Verhoeven AC, Felson DT.
    Arthritis Rheum; 2000 Jan; 43(1):22-9. PubMed ID: 10643696
    [Abstract] [Full Text] [Related]

  • 17. Examining the efficacy of biologic therapy: are there real differences?
    Fleischmann RM.
    J Rheumatol Suppl; 2002 Sep; 65():27-32. PubMed ID: 12236619
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.